Metis Global Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Metis Global Partners's LLY Position: Q2 2026 in Review
Metis Global Partners reduced its Eli Lilly (LLY) stake by 8.9% in Q2 2026, selling an estimated $4.36M and leaving 43,943 shares worth $52.7M. The position accounts for 1.2% of the portfolio, ranked #14.
Metis Global Partners first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $53.6M in Q4 2025. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Metis Global Partners held 43,943 shares of Eli Lilly worth $52.7M as of Q2 2026.
- Metis Global Partners sold 4,269 Eli Lilly shares in Q2 2026, an estimated $4.36M.
- Eli Lilly made up 1.2% of Metis Global Partners's portfolio in Q2 2026, its #14 holding.
- Metis Global Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- Metis Global Partners's Eli Lilly position peaked at $53.6M in Q4 2025.
- 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.